Cargando…

GLP1 Receptor Agonists Reduce Fluid Intake in Primary Polydipsia

Background Primary polydipsia, characterized by excessive fluid intake, carries the risk of water intoxication and hyponatremia, but treatment options are scarce. Glucagon-like peptide-1 (GLP-1) reduces appetite and food intake. In experimental models, they also play a role in thirst and drinking be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winzeler, Bettina Felicitas, Sailer, Clara Odilia, Coynel, David, Deborah, Vogt, Davide, Zanchi, Urwyler, Sandrine, Refardt, Julie, Christ-Crain, Mirjam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090681/ http://dx.doi.org/10.1210/jendso/bvab048.1052

Ejemplares similares

Validity of Different Copeptin Assays in the Differential Diagnosis of the Polyuria-Polydipsia Syndrome
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

THU113 Psychopathological Characteristics In Patients With Arginine Vasopressin Deficiency (Central Diabetes Insipidus) And Primary Polydipsia
por: Beck, Julia, et al.
Publicado: (2023)

Oxytocin Levels in Response to Pituitary Provocation Tests in Healthy Volunteers
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

THU122 Effects Of A GLP-1 Agonist On Consumption Of Alcohol In Patients Treated For Smoking Cessation
por: Probst, Leila Sofia, et al.
Publicado: (2023)

RF25 | PMON179 Role of Apparent Strong Ion Difference in the Differential Diagnosis of Thiazide Associated Hyponatremia
por: Monnerat, Sophie, et al.
Publicado: (2022)

OR27-6 Effects of the SGLT2-Inhibitor Empagliflozin in Patients With Chronic Syndrome of Inadequate Antidiuresis (SIAD) - Results of a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial
por: Berres, Manfred, et al.
Publicado: (2022)

FGF-21 levels in polyuria-polydipsia syndrome
por: Refardt, Julie, et al.
Publicado: (2018)

OR20-06 Diagnosing Central Diabetes Insipidus Using Copeptin Upon Hypertonic Saline Versus Arginine Stimulation
por: Refardt, Julie, et al.
Publicado: (2023)

OR2805 Plasma Sodium Increase Is Associated With An Increase In Bone Formation In Outpatients With Chronic SIAD—A Predefined Secondary Analysis Of The SANDx Trial
por: Monnerat, Sophie, et al.
Publicado: (2023)

OR17-01 Novel Provocation Test With MDMA (‘Ecstasy’) Reveals Oxytocin Deficiency As A New Pituitary Entity In Patients With Central Diabetes Insipidus - A Randomized Placebo-Controlled Trial
por: Atila, Cihan, et al.
Publicado: (2023)

ODP366 Copeptin Improves Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis
por: Sailer, Clara O, et al.
Publicado: (2022)

Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

ODP313 Glucagon-Stimulated Copeptin Measurements in the Differential Diagnosis of Diabetes Insipidus: A Double-Blind Randomized Placebo-Controlled Study
por: Atila, Cihan, et al.
Publicado: (2022)

LBMON62 Central Diabetes Insipidus From A Patients’ Perspective- From Management To Psychological Co-morbidities And Re-naming Of The Condition
por: Atila, Cihan, et al.
Publicado: (2022)

SUN-405 From Diabetes Insipidus to Primary Polydipsia: The Dynamic State of Water Balance in Neurosarcoidosis
por: Haridas, Arjun, et al.
Publicado: (2019)

THU112 Effect Of Protein Supplementation On Plasma Sodium Levels And Urinary Urea Excretion In Patients With Chronic Siad—A Monocentric Open-Label Proof-Of-Concept Study—The Treasure Study
por: Monnerat, Sophie, et al.
Publicado: (2023)

MON-441 Copeptin Response to Acute Hypoglycemia in Children and Adolescents
por: Drummond, Juliana, et al.
Publicado: (2019)

The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
por: Atila, Cihan, et al.
Publicado: (2022)

Relationship Between Oxytocin Levels and Brain Volume in Anorexia Nervosa Compared to Healthy Controls
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

ODP370 Disconnect Between Hypothalamic-Pituitary-Adrenal Activity and Amygdala Activation Using Novel Neuroimaging Fear Paradigm in Youth With Avoidant/Restrictive Food Intake Disorder
por: Sailer, Clara O, et al.
Publicado: (2022)

Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis
por: Refardt, Julie, et al.
Publicado: (2019)

Approach to the Patient: “Utility of the Copeptin Assay”
por: Christ-Crain, Mirjam, et al.
Publicado: (2022)

Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy
por: Yu, Xiaoling, et al.
Publicado: (2021)

Olfactory Neuroblastoma: The Adjunctive Role of Somatostatin Agonists After Surgery
por: Toral, Fernando Pazos, et al.
Publicado: (2021)

Empagliflozin Increases Short-Term Urinary Volume Output in Artificially Induced Syndrome of Inappropriate Antidiuresis
por: Refardt, Julie, et al.
Publicado: (2017)

SAT-260 Resolution of a Cystic Macroprolactinoma with Dopamine Agonist Therapy
por: Ansari, Mohammad Jamal Uddin, et al.
Publicado: (2020)

FRI312 Diplopia And Headache After Treatment With GnRH Agonist
por: Zakkar, Adam A, et al.
Publicado: (2023)

PMON58 Endogenous Oxytocin Response to Food Intake in Avoidant/Restrictive Food Intake Disorder Compared to Healthy Controls
por: Aulinas, Ana, et al.
Publicado: (2022)

PMON169 D2R Expression in Dopamine-Agonist Resistant Prolactinomas
por: Levine, Alice, et al.
Publicado: (2022)

SUN-448 Giant Prolactinomas: A Follow-Up of 25 Years with Dopamine Agonists
por: Mallea Gil, Susana, et al.
Publicado: (2019)

FRI275 Glutamate Receptor Agonists Stimulate Kisspeptin Neurons In The Arcuate Nucleus Of The Hypothalamus
por: Bearss, Robin, et al.
Publicado: (2023)

FRI311 GnRH Agonist Induced Pituitary Apoplexy In A Patient With Gonadotropinoma
por: Madahar, Inderpreet, et al.
Publicado: (2023)

EJE AWARD 2019: New diagnostic approaches for patients with polyuria polydipsia syndrome
por: Christ-Crain, Mirjam
Publicado: (2019)

SAT-247 Use of Double Dopamine Agonists in Giant Prolactinomas: A Series of 6 Cases
por: Kuan, Yueh Chien
Publicado: (2020)

MON-293 The Prevalence of Impulse Control Disorders in Patients with Acromegaly and Prolactinomas Treated with Dopamine Agonists
por: Ozkaya, Hande Mefkure, et al.
Publicado: (2020)

FRI303 PRL-R Variants Are Not Only Associated With Prolactinomas But Also With Dopamine Agonist Resistance
por: de Castro Moreira, Andrea Ramos, et al.
Publicado: (2023)

SAT602 The Regulation Of Food Intake Via Gastrointestinal Receptors
por: Bethea, Maigen Michelle, et al.
Publicado: (2023)

SUN-444 Efficacy and Safety of Dopamine Agonists in Psychiatric Patients Treated with Antipsychotics and Presenting a Macroprolactinoma
por: Allard, Lucie, et al.
Publicado: (2019)

SAT-442 Endogenous Oxytocin Response to Food Intake in Anorexia Nervosa
por: Aulinas, Ana, et al.
Publicado: (2019)

PMON91 Late Presentation of Pituitary Apoplexy Following Gonadotropin-Releasing Hormone Agonist for Prostate Cancer Treatment
por: Raj, Rishi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2p1r4tl60ealjl28hn3gmhgrh9